Mark B Pepys

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 11

Top Topics

Subarachnoid Hemorrhage

Mild Cognitive Impairment

Top Venues

European heart journal

Journal of internal medicine

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Amand Floriaan Schmidt, Chris Finan, Sandesh Chopade, Stephan Ellmerich, Martin N Rossor, Aroon D Hingorani, Mark B Pepys
Genetic evidence for serum amyloid P component as a drug target in neurodegenerative disorders. Open biology 14 (7) (2024)
Amand Floriaan Schmidt, Chris Finan, Sandesh Chopade, Stephan Ellmerich, Martin N Rossor, Aroon D Hingorani, Mark B Pepys
Genetic evidence for serum amyloid P component as a drug target in neurodegenerative disorders. Open biology 14 (7) (2024)
Amand Floriaan Schmidt, Chris Finan, Sandesh Chopade, Stephan Ellmerich, Martin N Rossor, Aroon D Hingorani, Mark B Pepys
Genetic evidence for serum amyloid P component as a drug target in neurodegenerative disorders. Open biology 14 (7) (2024)
Amand Floriaan Schmidt, Chris Finan, Sandesh Chopade, Stephan Ellmerich, Martin N Rossor, Aroon D Hingorani, Mark B Pepys
Genetic evidence for serum amyloid P component as a drug target in neurodegenerative disorders. Open biology 14 (7) (2024)
Ping K Yip, Zhou-Hao Liu, Shumaila Hasan, Mark B Pepys, Christopher E G Uff
Serum amyloid P component accumulates and persists in neurones following traumatic brain injury. Open biology 13 (12) (2023)
Ivana Slamova, Rozita Adib, Stephan Ellmerich, Michal R Golos, Janet A Gilbertson, Nicola Botcher, Diana Canetti, Graham W Taylor, Nigel B Rendell, Glenys A Tennent, Guglielmo Verona, Riccardo Porcari, P Patrizia Mangione, Julian David Gillmore, Mark B Pepys, Vittorio Bellotti, Philip N Hawkins, Raya Al-Shawi, J Paul Simons
Plasmin activity promotes amyloid deposition in a transgenic model of human transthyretin amyloidosis. Nature communications 12 (1) (2021)
Stephan Ellmerich, Graham W Taylor, Connor D Richardson, Thais Minett, Amand Floriaan Schmidt, Carol Brayne, Fiona E Matthews, Paul G Ince, Stephen B Wharton, Mark B Pepys, null null
Dementia in the older population is associated with neocortex content of serum amyloid P component. Brain communications 3 (4) (2021)
Mark B Pepys
Transthyretin amyloidosis: new answers but many questions. Journal of internal medicine 289 (6) (2021)
Mark B Pepys
C-reactive protein predicts outcome in COVID-19: is it also a therapeutic target? European heart journal 42 (23) (2021)
Duncan B Richards, Louise M Cookson, Sharon V Barton, Lia Liefaard, Thirusha Lane, David F Hutt, James M Ritter, Marianna Fontana, James C Moon, Julian D Gillmore, Ashutosh Wechalekar, Philip N Hawkins, Mark B Pepys
Repeat doses of antibody to serum amyloid P component clear amyloid deposits in patients with systemic amyloidosis. Science translational medicine 10 (422) (2019)
Raya Al-Shawi, Glenys A Tennent, David J Millar, Angela Richard-Londt, Sebastian Brandner, David John Werring, J Paul Simons, Mark B Pepys
Pharmacological removal of serum amyloid P component from intracerebral plaques and cerebrovascular Aβ amyloid deposits in vivo. Open biology 6 (2) (2016)